This finding supports current guidance for treating HIV infection in children.[31] Early and sustained ART limits the HIV reservoir and protects the CD4:CD8 ratio in adults.[13,32,33] The majority of our cohort did not receive ART until several years into childhood however, likely due to delayed diagnosis and historical availability and tolerability of pediatric ART formulations. The gene discussed is CD4; the disease is HIV infectious disease.